Empagliflozin with metformin hydrochloride (Jardiamet) Tab 12.5 mg with 1,000 mg metformin: Supply issue resolved
There was a supply issue affecting the 12.5 mg Jardiamet (pharmacode 2599732)
Update 25 October 2024
Boehringer Ingelheim have advised Pharmac that stock of empagliflozin with metformin hydrochloride (Jardiamet) Tab 12.5 mg with 1,000 mg metformin has been released to wholesalers. It may take another 1 to 2 weeks to reach pharmacies around the motu.
Affected product
Boehringer Ingelheim advises that two separate supply chain issues, combined with an increase in demand, have created an out of stock of:
- Chemical: Empagliflozin with metformin hydrochloride
- Presentation: Tab 12.5 mg with 1000 mg metformin hydrochloride
- Brand: Jardiamet
- Pharmacode: 2599740
- Subsidy: $58.56
- Measure / Qty: per 60
Other strengths remain available.
Alternative products
Both Boehringer Ingelheim and Pharmac are working to find a solution so people can continue to access treatment.
Expected resolution
Boehringer Ingelheim expects the next delivery of the affected product to be available by mid-November 2024.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)